Is ImmuCell Corp halal to invest in?

According to Musaffa's Shariah screening methodology, ImmuCell Corp (ICCC) is currently classified as HALAL as of April 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is ImmuCell Corp a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes ImmuCell Corp using these criteria to determine its compliance status.

Can Muslims buy shares of ImmuCell Corp?

Muslim investors may consider investing in ImmuCell Corp if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is ImmuCell Corp classified as HALAL?

Musaffa determines the Shariah status of ImmuCell Corp by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for ImmuCell Corp updated?

The Shariah compliance status of ImmuCell Corp may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like ImmuCell Corp become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of ImmuCell Corp?

You can check the latest Shariah compliance status of ImmuCell Corp on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

ICCC Shariah Compliance

Screening Methodology: AAOIFI

HALAL

Last Updated: April 03, 2026

Report Source: 2025 Annual Report

ImmuCell Corp. Stock Analysis ICCC

United States Health Care Micro Cap Report: 2025 Annual

ImmuCell Corp. engages in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. The company is headquartered in Portland, Maine and currently employs 73 full-time employees. The firm is engaged in the development, acquisition, manufacture, and sale of products that improve the health and productivity of dairy and beef cattle. The company operates in two business segments: Scours and Mastitis. The Scours segment is engaged in manufacturing and selling First Defense, a product used to prevent scours in newborn calves. The Mastitis segment includes products called California Mastitis Test and Re-Tain. Re-Tain, a novel treatment for subclinical mastitis in dairy cows, is in the late stages of development. The First Defense product line provides bovine antibodies that newborn calves need but are unable to produce on their own immediately after birth. Its product line extension, Tri-Shield First Defense, is the first calf-level, passive antibody product providing immediate immunity against each of the three causes of calf scours (E. Coli, coronavirus, and rotavirus).

Key Statistics of ImmuCell Corp (ICCC)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$8.40$8.92

Today's Open

$8.40

Volume

60.60K

P/E Ratio (TTM)

52 Week Range

$4.52$9.08

Market Cap

80.43M

Avg. Volume

24.31K

Dividend Yield

Financial Metrics & Statements of ImmuCell Corp (ICCC)

FAQ's for ImmuCell Corp (ICCC)

According to Musaffa’s Shariah screening methodology, ImmuCell Corp (ICCC) is currently classified as HALAL as of April 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.